Use of genetic markers to study cellular origin and development of tumors in human females.
D002051:Burkitt Lymphoma / Q000201:enzymology; D002460:Cell Line; D002999:Clone Cells; D003110:Colonic Neoplasms / Q000201:enzymology; D003884:Dermoid Cyst / Q000201:enzymology; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D006457:Hemoglobinuria, Paroxysmal; D006801:Humans; D007527:Isoenzymes / Q000032:analysis; D007889:Leiomyoma / Q000201:enzymology; D007926:Lesch-Nyhan Syndrome / Q000235:genetics; D007951:Leukemia, Myeloid / Q000235:genetics; D007962:Leukocytes / Q000201:enzymology; D009303:Nasopharyngeal Neoplasms / Q000209:etiology; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000201:enzymology / Q000209:etiology* / Q000235:genetics*; D009456:Neurofibromatosis 1 / Q000235:genetics; D010051:Ovarian Neoplasms / Q000201:enzymology; D010641:Phenotype; D012730:Sex Chromosomes; D012878:Skin Neoplasms / Q000201:enzymology; D002583:Uterine Cervical Neoplasms / Q000201:enzymology; D014594:Uterine Neoplasms / Q000201:enzymology
D007527:Isoenzymes; D005954:Glucosephosphate Dehydrogenase